Search Results - "Stull DM"

Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting.

Authors: Ludwig H Ramasamy K Mateos MV et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Feb; Vol. 24 (2), pp. e40-e49.e3. Date of Electronic Publication: 2023 Oct 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.

Authors: Thompson MA Boccadoro M Leleu X et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Mar; Vol. 23 (3), pp. e171-e181. Date of Electronic Publication: 2022 Dec 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.

Authors: Davies F Rifkin R Costello C et al.

Source: Annals of hematology [Ann Hematol] 2021 Sep; Vol. 100 (9), pp. 2325-2337. Date of Electronic Publication: 2021 May 10.

Publication Type: Comparative Study; Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data.

Authors: Ailawadhi S Cheng M Cherepanov D et al.

Source: Current problems in cancer [Curr Probl Cancer] 2024 Jun; Vol. 50, pp. 101078. Date of Electronic Publication: 2024 Mar 27.

Publication Type: Journal Article; Comparative Study; Research Support, N.I.H., Extramural

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE

INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.

Authors: Leleu X Lee HC Zonder JA et al.

Source: Future oncology (London, England) [Future Oncol] 2024 May; Vol. 20 (14), pp. 935-950. Date of Electronic Publication: 2024 Jan 10.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

In-class transition from bortezomib-based therapy to IRd is an effective approach in newly diagnosed multiple myeloma.

Authors: Rifkin RM Costello CL Birhiray RE et al.

Source: Future oncology (London, England) [Future Oncol] 2024 Jan; Vol. 20 (3), pp. 131-143. Date of Electronic Publication: 2023 Oct 09.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Comparison of health care costs and resource utilization for commonly used proteasome inhibitor-immunomodulatory drug-based triplet regimens for the management of patients with relapsed/refractory multiple myeloma in the United States.

Authors: Sanchez L Chari A Cheng M et al.

Source: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Nov; Vol. 29 (11), pp. 1205-1218. Date of Electronic Publication: 2023 Sep 30.

Publication Type: Journal Article

Journal Info: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE

Understanding Amyloidosis: Unraveling the Complexities and Therapeutic Approaches for Oncology Nurses.

Authors: Fogaren T Shelton AC Faller DV et al.

Source: Clinical journal of oncology nursing [Clin J Oncol Nurs] 2022 Jul 25; Vol. 26 (4), pp. 421-432.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oncology Nursing Press Country of Publication: United States NLM ID: 9705336 Publication Model: Print Cited Medium: Internet ISSN: 1538-067X (Electronic) Linking ISSN: 10921095 NLM ISO Abbreviation: Clin J Oncol Nurs

Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.

Authors: Hájek R Minařík J Straub J et al.

Source: Future oncology (London, England) [Future Oncol] 2021 Jul; Vol. 17 (19), pp. 2499-2512. Date of Electronic Publication: 2021 Mar 26.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Comparison of sargramostim and filgrastim in the treatment of chemotherapy-induced neutropenia.

Authors: Stull DM Bilmes R Kim H et al.

Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2005 Jan 01; Vol. 62 (1), pp. 83-7.

Publication Type: Clinical Trial; Comparative Study; Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Print ISSN: 1079-2082 (Print) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE

Colony-stimulating factors: beyond the effects on hematopoiesis.

Authors: Stull DM; Department of Pharmacy, New York-Presbyterian Hospital, 525 East 68th Street, Room K 04, New York, NY 10021, USA. dmstull@nyp.org

Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2002 Apr 01; Vol. 59 (7 Suppl 2), pp. S12-20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Print ISSN: 1079-2082 (Print) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE

Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach.

Authors: Hwa YL Fogaren T Sams A et al.

Source: Journal of the advanced practitioner in oncology [J Adv Pract Oncol] 2019 Jul; Vol. 10 (5), pp. 470-481. Date of Electronic Publication: 2019 Jul 01.

Publication Type: Journal Article; Review

Journal Info: Publisher: BroadcastMed LLC Country of Publication: United States NLM ID: 101550346 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2150-0878 (Print) Linking ISSN: 21500878 NLM ISO Abbreviation: J Adv Pract Oncol Subsets: PubMed not MEDLINE

INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma.

Authors: Costello C Davies FE Cook G et al.

Source: Future oncology (London, England) [Future Oncol] 2019 May; Vol. 15 (13), pp. 1411-1428. Date of Electronic Publication: 2019 Feb 28.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Targeted therapies for the treatment of leukemia.

Authors: Stull DM; New York-Presbyterian Hospital, 525 East 68th St, Department of Pharmacy, Room K-04, New York, NY 10021, USA.

Source: Seminars in oncology nursing [Semin Oncol Nurs] 2003 May; Vol. 19 (2), pp. 90-7.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 8504688 Publication Model: Print Cited Medium: Print ISSN: 0749-2081 (Print) Linking ISSN: 07492081 NLM ISO Abbreviation: Semin Oncol Nurs Subsets: MEDLINE

Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents.

Authors: Trovato JA Stull DM Finley RS

Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 1998 Jun 15; Vol. 55 (12), pp. 1269-74.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Print ISSN: 1079-2082 (Print) Linking ISSN: 10792082 NLM ISO Abbreviation: Am J Health Syst Pharm Subsets: MEDLINE